Klein Matthew B.'s Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jan 8, 2026
- Accession no.
- 0001808968-26-000005
- Filed
- Jan 8, 2026
- Trade date
- Jan 6-7, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $629.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Matthew B.CIK 0001808968 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | SSaleDisposed | −5,149 | $76.95 | −$396,215.55 | 399,983 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −3,016 | $77.48 | −$233,679.68 | 396,967 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.